Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Lessons learned while implementing an HIV/AIDS care and treatment program in rural Mozambique.

Moon TD, Burlison JR, Sidat M, Pires P, Silva W, Solis M, Rocha M, Arregui C, Manders EJ, Vergara AE, Vermund SH.

Retrovirology (Auckl). 2010 Apr 23;3:1-14.

2.
3.

Cost-effectiveness of antiretroviral therapy for prevention.

Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R.

Curr HIV Res. 2011 Sep;9(6):405-15. Review.

4.

The HIV/AIDS epidemic in sub-Saharan Africa: thinking ahead on programmatic tasks and related operational research.

Zachariah R, Van Damme W, Arendt V, Schmit JC, Harries AD.

J Int AIDS Soc. 2011 Jul 6;14 Suppl 1:S7. doi: 10.1186/1758-2652-14-S1-S7.

5.

Barriers to antiretroviral therapy adherence in rural Mozambique.

Groh K, Audet CM, Baptista A, Sidat M, Vergara A, Vermund SH, Moon TD.

BMC Public Health. 2011 Aug 16;11:650. doi: 10.1186/1471-2458-11-650.

6.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team..

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243.

7.

HIV prevention transformed: the new prevention research agenda.

Padian NS, McCoy SI, Karim SS, Hasen N, Kim J, Bartos M, Katabira E, Bertozzi SM, Schwartländer B, Cohen MS.

Lancet. 2011 Jul 16;378(9787):269-78. doi: 10.1016/S0140-6736(11)60877-5. Review.

8.

Has HIV/AIDS displaced other health funding priorities? Evidence from a new dataset of development aid for health.

Lordan G, Tang KK, Carmignani F.

Soc Sci Med. 2011 Aug;73(3):351-5; discussion 356-8. doi: 10.1016/j.socscimed.2011.05.045.

PMID:
21745705
9.

Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes.

Lahuerta M, Lima J, Elul B, Okamura M, Alvim MF, Nuwagaba-Biribonwoha H, Horowitz D, Fernandes R, Assan A, Abrams EJ, El-Sadr WM, Nash D.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):e75-86. doi: 10.1097/QAI.0b013e31822ac0a9.

10.

Towards an improved investment approach for an effective response to HIV/AIDS.

Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws E, Bartos M, Ghys PD, Opuni M, Barr D, Alsallaq R, Bollinger L, de Freitas M, Garnett G, Holmes C, Legins K, Pillay Y, Stanciole AE, McClure C, Hirnschall G, Laga M, Padian N; Investment Framework Study Group..

Lancet. 2011 Jun 11;377(9782):2031-41. doi: 10.1016/S0140-6736(11)60702-2.

PMID:
21641026
11.

Thirty years of HIV and AIDS: future challenges and opportunities.

Dieffenbach CW, Fauci AS.

Ann Intern Med. 2011 Jun 7;154(11):766-71. doi: 10.7326/0003-4819-154-11-201106070-00345.

PMID:
21628350
12.

An assessment of routine primary care health information system data quality in Sofala Province, Mozambique.

Gimbel S, Micek M, Lambdin B, Lara J, Karagianis M, Cuembelo F, Gloyd SS, Pfeiffer J, Sherr K.

Popul Health Metr. 2011 May 13;9:12. doi: 10.1186/1478-7954-9-12.

13.

Improving retention in the early infant diagnosis of HIV program in rural Mozambique by better service integration.

Ciampa PJ, Burlison JR, Blevins M, Sidat M, Moon TD, Rothman RL, Vermund SH.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):115-9. doi: 10.1097/QAI.0b013e31822149bf.

PMID:
21546845
14.

Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting.

Shah M, Johns B, Abimiku A, Walker DG.

AIDS. 2011 May 15;25(8):1093-102. doi: 10.1097/QAD.0b013e32834670b9.

PMID:
21505317
15.

Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique.

Lambdin BH, Micek MA, Koepsell TD, Hughes JP, Sherr K, Pfeiffer J, Karagianis M, Lara J, Gloyd SS, Stergachis A.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):e33-9. doi: 10.1097/QAI.0b013e3182167e90.

16.

Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.

Klausner JD, Serenata C, O'Bra H, Mattson CL, Brown JW, Wilson M, Mbengashe T, Goldman TM.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):292-5. doi: 10.1097/QAI.0b013e3182067d99.

PMID:
21317587
17.

Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambézia, Mozambique.

Cook RE, Ciampa PJ, Sidat M, Blevins M, Burlison J, Davidson MA, Arroz JA, Vergara AE, Vermund SH, Moon TD.

J Acquir Immune Defic Syndr. 2011 Apr;56(4):e104-9. doi: 10.1097/QAI.0b013e318207a535.

18.

Health workforce skill mix and task shifting in low income countries: a review of recent evidence.

Fulton BD, Scheffler RM, Sparkes SP, Auh EY, Vujicic M, Soucat A.

Hum Resour Health. 2011 Jan 11;9:1. doi: 10.1186/1478-4491-9-1.

19.

Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique.

Decroo T, Telfer B, Biot M, Maïkéré J, Dezembro S, Cumba LI, das Dores C, Chu K, Ford N.

J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e39-44. doi: 10.1097/QAI.0b013e3182055138.

PMID:
21084990
20.

The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa.

Walensky RP, Wood R, Fofana MO, Martinson NA, Losina E, April MD, Bassett IV, Morris BL, Freedberg KA, Paltiel AD; Cost-Effectiveness of Preventing AIDS Complications-International Investigators..

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):26-35. doi: 10.1097/QAI.0b013e3181fb8f24.

Items per page

Supplemental Content

Support Center